We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Temozolomide and Pazopanib Hydrochloride in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors That Cannot Be Removed By Surgery

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01465659
Recruitment Status : Recruiting
First Posted : November 7, 2011
Last Update Posted : October 26, 2017
Robert H. Lurie Cancer Center
National Comprehensive Cancer Network
Information provided by (Responsible Party):
Northwestern University

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : August 2019
  Estimated Study Completion Date : August 2020